elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.
Company profile
Ticker
ELAN
Exchange
Website
CEO
Jeff Simmons
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Dista Products Limited • EIO Insurance Company, Inc. • Elanco (Shanghai) Animal Health Co., Ltd. • Elanco (Sichuan) Animal Health Co., Ltd. • Elanco (Taiwan) Animal Health Co. Ltd. • Elanco (Thailand) Ltd. • Elanco Animal Health (Pty) Ltd. • Elanco Animal Health GmbH • Elanco Animal Health Holdings BV • Elanco Animal Health Korea Ltd. ...
ELAN stock data
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
19 Apr 24
DEF 14A
Definitive proxy
19 Apr 24
PRE 14A
Preliminary proxy
8 Apr 24
8-K
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
1 Apr 24
DEFA14A
Additional proxy soliciting materials
29 Feb 24
DEFA14A
Additional proxy soliciting materials
29 Feb 24
DFAN14A
Additional proxy materials by non-management
29 Feb 24
10-K
2023 FY
Annual report
26 Feb 24
8-K
Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results
26 Feb 24
8-K
Elanco Announces Sale of Aqua Business for $1.3 Billion
5 Feb 24
Transcripts
ELAN
Earnings call transcript
2023 Q4
26 Feb 24
ELAN
Earnings call transcript
2023 Q3
7 Nov 23
ELAN
Earnings call transcript
2023 Q2
7 Aug 23
ELAN
Earnings call transcript
2023 Q1
9 May 23
ELAN
Earnings call transcript
2022 Q4
21 Feb 23
ELAN
Earnings call transcript
2022 Q3
8 Nov 22
ELAN
Earnings call transcript
2022 Q2
8 Aug 22
ELAN
Earnings call transcript
2022 Q1
9 May 22
ELAN
Earnings call transcript
2021 Q4
24 Feb 22
ELAN
Earnings call transcript
2021 Q3
5 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 369.00 mm | 369.00 mm | 369.00 mm | 369.00 mm | 369.00 mm | 369.00 mm |
Cash burn (monthly) | (no burn) | 7.58 mm | 365.67 mm | 96.42 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | 51.76 mm | 2.50 bn | 658.12 mm | n/a | n/a |
Cash remaining | n/a | 317.24 mm | -2.13 bn | -289.12 mm | n/a | n/a |
Runway (months of cash) | n/a | 41.8 | -5.8 | -3.0 | n/a | n/a |
Institutional ownership, Q3 2023
99.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 347 |
Opened positions | 54 |
Closed positions | 50 |
Increased positions | 115 |
Reduced positions | 110 |
13F shares | Current |
---|---|
Total value | 5.29 tn |
Total shares | 489.99 mm |
Total puts | 894.31 k |
Total calls | 1.17 mm |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
Dodge & Cox | 84.20 mm | $946.45 bn |
Primecap Management | 49.17 mm | $552.66 bn |
Vanguard | 49.00 mm | $550.78 bn |
BLK Blackrock | 27.12 mm | $304.82 bn |
T. Rowe Price | 19.92 mm | $222.12 bn |
BAYRY Bayer Aktiengesellschaft | 18.45 mm | $538.64 mm |
Shapiro Capital Management | 15.80 mm | $177.54 bn |
Black Creek Investment Management | 15.52 mm | $174.48 bn |
Citadel Advisors | 13.82 mm | $155.29 bn |
Dimensional Fund Advisors | 11.28 mm | $126.77 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Apr 24 | Rajeev A. Modi | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 12.95 | 106.921 | 1.38 k | 717.739 |
19 Apr 24 | Jeffrey N Simmons | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 12.95 | 213.841 | 2.77 k | 1,438.284 |
5 Apr 24 | Jeffrey N Simmons | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 15.56 | 177.972 | 2.77 k | 1,224.443 |
5 Apr 24 | Rajeev A. Modi | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 15.56 | 88.986 | 1.38 k | 610.819 |
3 Apr 24 | Bettington Timothy J | Common Stock | Payment of exercise | Dispose F | No | No | 15.43 | 23,557 | 363.48 k | 106,387 |
News
Bloomberg Reported Late Sunday: Activist Investor Ancora Secures Two Elanco Board Seats
1 Apr 24
Piper Sandler Reiterates Neutral on Elanco Animal Health, Raises Price Target to $18
12 Mar 24
Goldman Sachs Maintains Sell on Elanco Animal Health, Raises Price Target to $14
27 Feb 24
Morgan Stanley Maintains Overweight on Elanco Animal Health, Raises Price Target to $17
27 Feb 24
Breaking Down Elanco Animal Health: 6 Analysts Share Their Views
27 Feb 24
Press releases
Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
17 Apr 24
Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary
4 Mar 24
Elanco Animal Health is Executing on Plan to Deliver for Shareholders
29 Feb 24
Beef 'agtech' company Cattler launches interface with Elanco for its Benchmark program
8 Feb 24
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2023 Financial Results Announcement
8 Feb 24